Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. and Encourages Investors to Contact the Firm Before September 22nd
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers REPL
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against RxSight, Inc. and Encourages Investors to Contact the Firm Before September 22nd
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers RXST
ALTO NEUROSCIENCE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Alto Neuroscience, Inc. (ANRO) and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers ANRO
Successful Showcase of ParaZero’s DefendAir System with Israel’s Defense and National Authorities and Trexmatic’s Autonomous Robot
From ParaZero Technologies Ltd.
Via GlobeNewswire
Tickers PRZO
Bragar Eagel & Squire, P.C. Reminds Investors of Tronox, Savara, and Fly-E that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers FLYE SVRA TROX
NEOGEN FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Neogen Corporation and Encourages Investors to Contact the Firm Before September 16th
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers NEOG
Discovery Announces Agreement for US$250 Million Revolving Credit Facility
From Discovery Silver Corp.
Via GlobeNewswire
Tickers DSVSF TSX:DSV
Palvella Therapeutics Completes Enrollment in Phase 2 TOIVA Trial of QTORIN™ Rapamycin for Cutaneous Venous Malformations
From Palvella Therapeutics Inc.
Via GlobeNewswire
Tickers PVLA
Habit Burger & Grill Celebrates Second Restaurant Launch in Rancho Cucamonga
From Habit Burger & Grill
Via GlobeNewswire
Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Tickers ASX ATHE
Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, Nutex, LifeMD, and Snap that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers LFMD NUTX SNAP UNCY
Bragar Eagel & Squire, P.C. Reminds Investors of KinderCare, CTO Realty, PubMatic, and Charter Communications that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers CHTR CTO KLC PUBM
SPECTRUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
HALA raises $157m in one of the Middle East’s largest fintech Series B rounds, led by TPG and Sanabil Investments
From Hala
Via GlobeNewswire
Celestica to Hold Q3 2025 Financial Results Conference Call and 2025 Investor and Analyst Day
From Celestica International LP
Via GlobeNewswire
Tickers CLS TSX:CLS
Bragar Eagel & Squire, P.C. Reminds Investors of Altimmune and SelectQuote that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers ALT SLQT
NOVO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers NVO
LINEAGE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Lineage, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Tickers LINE
Mobix Labs Files Form 425 With the SEC, Announces Intention to Launch Hostile Tender Offer for Peraso; Criticizes Recent Dilutive Financing and Efforts to Restrict Shareholder Communications
From Mobix Labs, Inc.
Via GlobeNewswire
Tickers MOBX PRSO
Forterra and Volvo Defense Demonstrate Integrated Autonomous Mission Systems in Vehicle Platforms
From Forterra
Via GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lantheus Holdings, Inc. (NASDAQ: LNTH)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers LNTH
OTC Markets Group Expands Data Availability via ICE Consolidated Feed, Unlocking Greater Global Access to Overnight Trading
From OTC Markets
Via GlobeNewswire
Tickers ICE OTCM
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Sable Offshore Corp. (NYSE: SOC)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers SOC
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Flywire Corporation (NASDAQ: FLYW)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers FLYW
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S (NYSE: NVO)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers NVO
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against KinderCare Learning Companies, Inc. (NYSE: KLC)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers KLC
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Dow Inc. (NYSE: DOW)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers DOW
Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases
From Monte Rosa Therapeutics, Inc.
Via GlobeNewswire
Tickers GLUE
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against C3.ai, Inc. (NYSE: AI)
From Bernstein Liebhard LLP
Via GlobeNewswire
Tickers AI
Can-Fite Reports Complete Resolution of Esophageal Varices in Decompensated Cirrhosis Patient Treated with Namodenoson
From Can-Fite BioPharma Ltd.
Via GlobeNewswire
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.